SCHEMBL27475342

SCHEMBL27475342

Fc1cccc(-c2nnc(CCl)o2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.65
LMNA P02545 1/20 0.65
NOTUM Q6P988 5/20 0.58
PTK2 Q05397 1/20 0.55
TSHR P16473 3/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
GSK3B P49841 2/20 0.45
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
HPGD P15428 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
TP53 P04637 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
GUSB P08236 1/20 0.42
NLRP3 Q96P20 1/20 0.41
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31413771 1.00 ALDH1A1 (0.65) ALDH1A1LMNANOTUMPTK2TSHR
SCHEMBL3822281 0.84 NOTUM (0.65) ALDH1A1LMNANOTUMPTK2TSHR
SCHEMBL30566753 0.82 ALDH1A1 (0.67) ALDH1A1LMNANOTUMPTK2TSHR
SCHEMBL1545045 0.82 ALDH1A1 (0.67) ALDH1A1LMNANOTUMPTK2TSHR
SCHEMBL30566768 0.81 LMNA (0.65) ALDH1A1LMNANOTUMTSHRPOLB
SCHEMBL30566766 0.81 ALDH1A1 (0.65) ALDH1A1LMNANOTUMPTK2TSHR
SCHEMBL30566780 0.81 ALDH1A1 (0.65) ALDH1A1LMNANOTUMPTK2TSHR
SCHEMBL1544503 0.81 LMNA (0.65) ALDH1A1LMNANOTUMTSHRPOLB
SCHEMBL29077294 0.81 ALDH1A1 (0.65) ALDH1A1LMNANOTUMPTK2TSHR
SCHEMBL28531936 0.81 LMNA (0.65) ALDH1A1LMNANOTUMTSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103288817-A Schiff base ramification based on 1,3,4-thiadiazole and 1,3,4-oxadiazole as well as preparation method and application thereof UNIV TIANJIN TECHNOLOGY 2013-09-11 CN claimed
US-20240300932-A1 N-PHENYLIMINE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF GUIZHOU UNIVERSITY (CN) 2024-09-12 US disclosed
WO-2024174317-A1 N-PHENYLIMINE-CONTAINING DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 贵州大学 2024-08-29 WO disclosed
CN-116731003-A N-phenylimine-containing derivative, and preparation method and application thereof 贵州大学 2023-09-12 CN disclosed
CN-103288817-A Schiff base ramification based on 1,3,4-thiadiazole and 1,3,4-oxadiazole as well as preparation method and application thereof UNIV TIANJIN TECHNOLOGY 2013-09-11 CN disclosed
CN-1177846-C Oxa(thia)diazolylpyridazinone derivative and its preparing process and application 华东理工大学 2004-12-01 CN disclosed
CN-1276373-A Oxa(thia)diazolylpyridazinone derivative and its preparing process and application HUADONG SCIENCE & ENGINEERING (CN) 2000-12-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300932-A1 N-PHENYLIMINE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF PNMT, NNMT, PAH ALDH1A1 780/4885LMNA 2548/4885NOTUM 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.